Multiple Myeloma

Reference work entry


Hematologic malignancy characterized by major life-threatening complications such as bone disease, infections, renal failure, anemia. Anemia is present in two thirds of patients at diagnosis of myeloma and reflects the course of the disease since it worsens during resistant or progressive disease, but ameliorates when the disease is controlled by treatment. rHuEpo and Darbepoetin alfa have been used in myeloma to increase Hb concentration, reduce RBC transfusion requirement and improve QOL.


Public Health Renal Failure Multiple Myeloma Social Policy Progressive Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Springer Science+Business Media LLC 2010

Personalised recommendations